BDBM301082 4-[2-(4-aminopiperidin-1-yl)-5-(1,2- dimethylbenzimidazol-5-yl)pyrimidin- 4-yl]benzonitrile::US10131664, Example 75
SMILES: Cc1nc2cc(ccc2n1C)-c1cnc(nc1-c1ccc(cc1)C#N)N1CCC(N)CC1
InChI Key: InChIKey=DDMIJGTXTGXKKR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM301082 (4-[2-(4-aminopiperidin-1-yl)-5-(1,2- dimethylbenzi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc. US Patent | Assay Description The enzymatic assay of LSD1 activity is based on Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The inhibitory properties ... | US Patent US10131664 (2018) BindingDB Entry DOI: 10.7270/Q2JD4ZV1 | |||||||||||
More data for this Ligand-Target Pair |